BioCentury
ARTICLE | Clinical News

Cevira: Phase IIb data

December 24, 2012 8:00 AM UTC

A double-blind, international Phase IIb trial in 262 patients with cervical intraepithelial neoplasia (CIN) 1/2 showed that 5% intravaginal Cevira non-significantly improved the 3-month disease cleara...